Verition Fund Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,969
Closed -$4.18M 2989
2025
Q4
$4.18M Sell
16,969
-14,364
-46% -$3.02M 0.02% 1016
2025
Q3
$5.53M Buy
31,333
+4,819
+18% +$721K 0.03% 1051
2025
Q2
$3.64M Buy
26,514
+7,889
+42% +$1.16M 0.02% 1438
2025
Q1
$3.36M Sell
18,625
-6,277
-25% -$1.06M 0.02% 1183
2024
Q4
$3.9M Buy
24,902
+8,902
+56% +$1.58M 0.02% 1069
2024
Q3
$2.91M Sell
16,000
-1,989
-11% -$384K 0.02% 1190
2024
Q2
$3.3M Sell
17,989
-43,811
-71% -$7.36M 0.03% 980
2024
Q1
$11M Sell
61,800
-34,158
-36% -$4.74M 0.11% 303
2023
Q4
$11.9M Sell
95,958
-31,112
-24% -$3.45M 0.12% 193
2023
Q3
$14.7M Buy
127,070
+35,338
+39% +$4.31M 0.2% 141
2023
Q2
$10.8M Sell
91,732
-1,912
-2% -$195K 0.17% 181
2023
Q1
$7.5M Buy
93,644
+13,083
+16% +$1.03M 0.12% 256
2022
Q4
$6.38M Buy
80,561
+12,909
+19% +$958K 0.12% 250
2022
Q3
$4.71M Buy
67,652
+12,908
+24% +$933K 0.06% 433
2022
Q2
$3.59M Buy
54,744
+23,578
+76% +$1.47M 0.07% 384
2022
Q1
$2.07M Sell
31,166
-44,948
-59% -$2.81M 0.04% 942
2021
Q4
$5.32M Buy
76,114
+10,069
+15% +$586K 0.07% 336
2021
Q3
$3.45M Buy
66,045
+47,464
+255% +$2.81M 0.05% 383
2021
Q2
$1.26M Sell
18,581
-51,266
-73% -$3.58M 0.02% 702
2021
Q1
$5.38M Sell
69,847
-7,697
-10% -$560K 0.1% 184
2020
Q4
$4.65M Buy
77,544
+21,515
+38% +$1.07M 0.07% 214
2020
Q3
$2.41M Sell
56,029
-10,457
-16% -$454K 0.08% 217
2020
Q2
$2.75M Sell
66,486
-19,504
-23% -$938K 0.13% 171
2020
Q1
$3.72M Buy
85,990
+61,798
+255% +$3.23M 0.28% 104
2019
Q4
$1.34M Sell
24,192
-45,002
-65% -$2.21M 0.04% 364
2019
Q3
$2.4M Buy
69,194
+6,544
+10% +$293K 0.14% 205
2019
Q2
$2.52M Buy
+62,650
New +$2.05M 0.13% 195

Other funds holding KRYS